Diurnal preference, mood and the response to morning light in relation to polymorphisms in the human clock gene PER3
PER3 gene polymorphisms have been associated with differences in human sleep-wake phenotypes, and sensitivity to light. The aims of this study were to assess: i ) the frequency of allelic variants at two PER3 polymorphic sites (rs57875989 length polymorphism: PER3 4 , PER3 5 ; rs228697 SNP: PER3 C ,...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2017-07, Vol.7 (1), p.6967-10, Article 6967 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PER3
gene polymorphisms have been associated with differences in human sleep-wake phenotypes, and sensitivity to light. The aims of this study were to assess:
i
) the frequency of allelic variants at two
PER3
polymorphic sites (rs57875989 length polymorphism:
PER3
4
,
PER3
5
; rs228697 SNP:
PER3
C
,
PER3
G
) in relation to sleep-wake timing;
ii
) the effect of morning light on behavioural/circadian variables in
PER3
4
/PER3
4
and
PER3
5
/PER3
5
homozygotes. 786 Caucasian subjects living in Northern Italy donated buccal DNA and completed diurnal preference, sleep quality/timing and sleepiness/mood questionnaires. 19
PER3
4
/PER3
4
and 11
PER3
5
/PER3
5
homozygotes underwent morning light administration, whilst monitoring sleep-wake patterns and the urinary 6-sulphatoxymelatonin (aMT6s) rhythm. No significant relationship was observed between the length polymorphism and diurnal preference. By contrast, a significant association was observed between the
PER3
G
variant and morningness (OR = 2.10), and between the
PER3
G
-
PER3
4
haplotype and morningness (OR = 2.19), for which a mechanistic hypothesis is suggested. No significant differences were observed in sleep timing/aMT6s rhythms between
PER3
5
/PER3
5
and
PER3
4
/PER3
4
subjects at baseline. After light administration,
PER3
4
/PER3
4
subjects advanced their aMT6s acrophase (p |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-06769-w |